Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Gyu Chul Oh"'
Autor:
Hyuck Moon Kwon, Chang Gyu Park, Kwang Je Lee, Byung Su Yoo, Gyu Chul Oh, In Jai Kim, Seong Hoon Park, Seung Hwan Han, Gyo-Seung Hwang, Hyo-Soo Kim
Publikováno v:
Drug Design, Development and Therapy
Seung Hwan Han,1 Gyu Chul Oh,2 Hyuck Moon Kwon,3 Chang Gyu Park,4 In Jai Kim,5 Gyo-Seung Hwang,6 Byung Su Yoo,7 Seong Hoon Park,8 Kwang Je Lee,9 Hyo-soo Kim21Division of Cardiology, Department of Internal Medicine, Gachon University College of Medici
Publikováno v:
Drug Design, Development and Therapy
Gyu Chul Oh,1 Kwon Wook Joo,2 Myung-A Kim,3 Dong-Ju Choi,4 Yoon Jun Kim,5 Hae-Young Lee1 1Division of Cardiology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea; 2Division of Nephrology, Department of Internal Medic
Autor:
Sang-Hyun Ihm, Youngjin Choi, Sang Hong Baek, Ki Hoon Han, Soo Joong Kim, Jung Hoon Sung, Gyu Chul Oh, Jin Ok Jeong, Moo Hyun Kim, Eun-Seok Shin, Min Su Hyon, Joon Hyung Doh, Moo Yong Rhee, Jung-Kyu Han, Byung Su Yoo, Byoung Kwon Lee, Hyunsu Kim, Sang-Hyun Kim, Hyo-Soo Kim, Jang Hyun Cho, Kyung Soon Hong, Jang Ho Bae, Jay Young Rhew
Publikováno v:
Clinical therapeutics. 40(5)
Hypertension and dyslipidemia are 2 risk factors of cardiovascular disease that often present simultaneously. Traditionally, treatment of these multiple conditions required separate medications for each disease, which may result in poor compliance an
Publikováno v:
Clinical Therapeutics. 34:1940-1947
Background Amlodipine is a racemic mixture of (R)- and (S)-enantiomers. It has been suggested that removing the therapeutically inactive (R)-enantiomer will reduce adverse events while preserving the agent's efficacy. Women experience more adverse ef